We serve Chemical Name:Ethyl 7-chloroimidazo[1,2-c]pyrimidine-2-carboxylate CAS:1105187-40-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![Ethyl 7-chloroimidazo[1,2-c]pyrimidine-2-carboxylate](https://a.dearchem.com/CAS2/1105187-40-3.png)
Chemical Name:Ethyl 7-chloroimidazo[1,2-c]pyrimidine-2-carboxylate
CAS.NO:1105187-40-3
Synonyms:Imidazo[1,2-c]pyrimidine-2-carboxylic acid, 7-chloro-, ethyl ester;Ethyl 7-chloroimidazo[1,2-c]pyrimidine-2-carboxylate
Molecular Formula:C9H8ClN3O2
Molecular Weight:225.632
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.5±0.1 g/cm3
Index of Refraction:1.648
PSA:56.49000
Exact Mass:225.030502
LogP:1.41
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Imidazo[1,2-c]pyrimidine-2-carboxylic acid, 7-chloro-, ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 7-chloroimidazo[1,2-c]pyrimidine-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Imidazo[1,2-c]pyrimidine-2-carboxylic acid, 7-chloro-, ethyl ester Use and application,Imidazo[1,2-c]pyrimidine-2-carboxylic acid, 7-chloro-, ethyl ester technical grade,usp/ep/jp grade.
Related News: Competition is indeed “severe” from local firms, Wang said, but the company is working to add new drugs and indications to the market and is noticing increased volumes from national reimbursement deals. 1,1-dichloro-4-methylenespiro(2.5)octane manufacturers “With our commercial capability, we will definitely make sure that we can stabilize and continue growing,” Wang said. 3-(3-hydroxy-24,34-tetraoxidan-2-enyl)-6-(2,4,4-trihydroxy-24,44-pentaoxidaneyl)-14,24,34,44,54,64-hexaoxine-1,2,4,5-tetraol suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. methyl 1,5-naphthyridin-4-yl sulfone vendor & factory.
